On May 28, Genertec Meheco held its second extraordinary general meeting for 2025, where the proposal to acquire 100% of Golden Harvest was reviewed and approved.

In recent years, the pharmaceutical e-commerce market has grown rapidly, driven by industry policies such as "prescription outflow" and "online payment via medical insurance," which have accelerated the shift of drug sales from hospitals to the external market, giving rise to new retail in pharmaceuticals. Meanwhile, China's large population, increasing aging trend, and heightened public health awareness have collectively fueled the rapid development of the health industry. Against this backdrop, Genertec Meheco is actively seeking to transition from a traditional pharmaceutical enterprise to a health-focused enterprise, with the acquisition of Golden Harvest representing a significant step in its strategic transformation.

After acquiring Golden Harvest, Genertec Meheco will leverage Golden Harvest's professional service planning and marketing capabilities to shape a unique brand image while building a big health product system. This will facilitate the integration of online and offline channels and enhance the ability to integrate resources within the industry chain. Both parties will explore market potential and achieve synergistic effects through resource sharing and complementary advantages. Genertec Meheco plans to implement enterprise management integration and optimize its organizational structure post-acquisition. This includes establishing a big health and e-commerce division centered around Golden Harvest, systematically promoting the transformation of big health and e-commerce businesses. By focusing on personal health consumption and capitalizing on the advantages of product plus service, Genertec Meheco intends to coordinate the development of online and offline channels. Through a positive integration of both parties, enhanced performance outcomes are expected.

In the context of the deep advancement of the "Healthy China" strategy, this acquisition embodies the "traditional pharmaceutical company + e-commerce platform" model, providing a development framework for Genertec Meheco's digital transformation and expansion into the big health business. This move strongly supports Genertec Meheco's transformation, upgrading, and intelligence initiatives.